New HHS Chief Alex Azar Supports LDT Regulation, Cost-Saving Bundles
Alex Azar was confirmed as the next secretary of Health and Human Services with strong industry support. Azar comes to the role with some homework to do on key FDA medtech policies, but has expressed support for risk-based regulation of lab-developed tests and cost-saving bundled-payment models.
You may also be interested in...
Chuck Schumer, the top Democratic senator, is calling on HHS secretary Alex Azar to resign, accusing him of putting politics over public health.
At back-to-back congressional hearings on Feb. 14 and 15, US Health and Human Services Secretary Alex Azar seemed to satisfy lawmakers' questions on how he would use his budget to fix problems in the durable medical equipment bidding program and provide telehealth reimbursements under Medicare, but conceded that lab-developed test regulations are a complicated issue.
The latest value-based payment models sponsored by the US Centers for Medicare and Medicaid Services and other institutions lack adequate quality measures to effectively assess the value of medical technologies. That's resulting in patients losing access to device products, says a Discern Health white paper sponsored by AdvaMed.